Pay in 4 interest-free payments of $6.20 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
- diabetes
Retatrutide Trial: 45% of Patients Lost Over 30% of Their Body Weight A new injectable weight loss treatment, in evaluation phase, called retatrutide has delivered some of the most striking results yet seen in a clinical trial for obesity
Semaglutide (Wegovy) was tested in clinical trials and was found to help people lose an average of 21% of their starting weight after 72 weeks on the 7.2mg maintenance dose
Elan Pharmaceuticals has developed Myocet , a non-PEGylated liposomal formulation of doxorubicin (NPLD), which has demonstrated reduced cardiotoxicity and enhanced bioavailability
Patients with type 2 diabetes on semaglutide are at very low risk for DKA, though rare case reports exist, particularly in the context of significant insulin dose reductions
US$ 24.04
US$ 28.12
US$ 27.01
![Acetyl-L-cystine bis-methyl ester [Disulfide bond] – Chem-Impex](https://www.chemimpex.com/cdn/shop/files/04348_image_grande.gif?v=1725026523)
